Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces that its 2014 annual financial report is available on its website, which includes the 2014 annual financial statements approved by its Board of Directors on 22 April 2015. Quantum Genomics also presents an update on its activity for the first quarter of 2015.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/04/QGC_PR_RESULTS-2014_20150422_UK.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
